Showing results (611-620 of 6,486) with videos related to
Sort By:
Pageof 649
Journal of Thrombosis and Haemostasis : JTH|June 6, 2017
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease miceL L Swystun, I Georgescu, J Mewburn, et al.Journal of Thrombosis and Haemostasis : JTH|June 1, 2017
Intracellular origin and ultrastructure of platelet-derived microparticlesA A Ponomareva, T A Nevzorova, E R Mordakhanova, et al.Journal of Thrombosis and Haemostasis : JTH|June 3, 2017
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levelsJ-D Studt, L Alberio, A Angelillo-Scherrer, et al.Journal of Thrombosis and Haemostasis : JTH|February 26, 2010
Strength and failure of fibrin fiber branchpointsC R Carlisle, E A Sparks, C Der Loughian, et al.Journal of Thrombosis and Haemostasis : JTH|February 26, 2010
Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by plateletsK M Baeten, M C Richard, S M Kanse, et al.Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.Journal of Thrombosis and Haemostasis : JTH|December 23, 2009
Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA studyD Green, C Chan, J Kang, et al.Journal of Thrombosis and Haemostasis : JTH|September 27, 2016
A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjectsD Lee, S Nayak, S W Martin, et al.Journal of Thrombosis and Haemostasis : JTH|April 13, 2018
Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta-analysis of the management outcome studiesD Belzile, S Jacquet, L Bertoletti, et al.Journal of Thrombosis and Haemostasis : JTH|January 12, 2010
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleedingS Schulman, F A SpencerPageof 649